The programmed death-1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) (34, 35) and cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) immune checkpoints have gained considerable attention in the treatment of pancreatic cancer (36). The gene discussed is CD274; the disease is pancreatic neoplasm.